One-Stop Drug Solid-State Research

CD Formulation's drug solid-state research team has extensive knowledge of crystal chemistry, and can provide systematic drug solid-state research. Our goal is to help customers choose reliable solid forms in preclinical research and clinical trials, and to assist in global pharmaceutical research and development.

Why Do One-Stop Drug Solid-State Research?

Solid-state research can be used as an important means to improve the drug's pharmaceutical properties, reduce development risks, ensure product quality, and establish effective patent barriers. It is an essential part of the drug development process. For innovative pharmaceutical companies, solid state research is a key tool to determine the advantageous form in a timely manner, expand the scope of patent protection, and extend the product life cycle. For generic pharmaceutical companies, solid state research is expected to break through the original patent barriers, improve the technical content of products, and obtain market first-mover benefits.

Our One-Stop Drug Solid-State Research Include:

• Polymorph, Salt & Cocrystal Screening and Selection

Screening and selection the advantages of solid forms of drugs, improving the properties of pharmaceuticals, and establishing technical barriers.

• Single Crystal Growth & Structure Determination

Using high-throughput single crystal culture and X-ray single crystal diffraction technology or MicroED to achieve the integration of single crystal growth and structure determination services to meet the needs of rapid and accurate identification of drug molecules.

• Solid-State Characterization

Supporting qualitative/quantitative research on the crystal forms, crystal habit/morphology, powder particle size, and moisture absorption of drug raw materials, excipients, and formulations. We are particularly adept at providing solutions and technical support for qualitative identification of API crystal forms in low-specification formulations or formulations with excipient interference.

• Crystallization Process Development

Combined with the crystallization properties of the product and industrial reality, the optimal crystallization process is rationally designed to solve problems related to crystal form and crystal habit such as oil precipitation during the crystallization process, uncontrolled crystallization process, and product moisture, dissolved residues, crystal form, and particle size that do not meet standards, so as to meet customer sample amplification needs and obtain target solid-state form efficiently and stably.

Advantages of Our One-Stop Drug Solid-State Research Services

• Rich project experience: we have been deeply engaged in the field of solid-state drug research for many years, with rich experience in developing industry projects, and are able to develop optimal screening strategies based on material properties.
• Advanced technology: we have dozens of sample preparation methods and supporting facilities, actively seeking breakthroughs and innovations in the latest technologies, and constantly exploring cutting-edge solid-state research techniques.
• Responsible attitude: we provide detailed professional program evaluation at the beginning of the project, conduct regular project progress reports in the middle of the project, provide rapid response to problems at any time, and deliver detailed and comprehensive results at the end of the project.
• Rapid delivery: we have efficient experimental processes and operational experience to deliver results in a timely manner to meet time requirements.
• Flexible customization services: we provide customized solutions according to customer needs, and closely cooperate with the project.

CD Formulation's business covers all aspects of drug formulation, drug ingredients, drug development, drug testing, drug optimization, etc. We provide one-stop integrated services from pre-clinical to commercial manufacturing for our global pharmaceutical and biotech partners. In the future, we will continue to strengthen our technological barriers and enhance our R&D production and service capabilities to provide quality and diversified services to more new drug development start-ups, medium and large companies as well as pharmaceutical companies around the world. If you have a requirement about our services, please contact us by phone or email, our colleagues will reply to you within three working days.